Completed NA INTERVENTIONAL 2-arm NCT03398668

Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Sponsor: Neurolief Ltd.

Conditions Migraine

Interventions Relievion Device- Sham stimulation Relievion device- Treatment stimulation

Updated 9 times since 2018 Last updated: Mar 11, 2019 Started: Feb 22, 2018 Primary completion: Dec 30, 2018 Completion: Dec 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Migraine, this trial is completed. The trial is conducted by Neurolief Ltd. and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2019 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Dec 2018 — Apr 2019 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 4 earlier versions

Aug 2018 — Dec 2018 [monthly]

Recruiting NA
Jun 2018 — Aug 2018 [monthly]

Recruiting NA
Mar 2018 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2018 — Mar 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neurolief Ltd.

Data source: Neurolief Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Netanya, Israel